AstraZeneca to acquire Gracell in $1.2 billion deal



AstraZeneca plc announced on Tuesday that it is set to acquire China-based global biopharmaceutical firm Gracell Biotechnologies in a deal estimated to be worth around $1.2 billion to use the latter…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento